State Street SPDR SandP Pharmaceuticals ETF (XPH) |
| 56.59 0.716 (1.28%) 04-13 16:00 |
| Open: | 56.135 |
| High: | 56.6099 |
| Low: | 55.54 |
| Volume: | 44,402 |
| Market Cap: | 228(M) |
| PE Ratio: | 18.75 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 66.61 |
| Resistance 1: | 57.03 |
| Pivot price: | 54.18 |
| Support 1: | 53.45 |
| Support 2: | 51.23 |
| 52w High: | 58.84 |
| 52w Low: | 37.31 |
T
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 07 Apr 2026
SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended December 31, 2025 - marketscreener.com
Fri, 03 Apr 2026
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Yahoo Finance
Wed, 01 Apr 2026
Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda - Benzinga
Mon, 30 Mar 2026
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Thu, 29 Jan 2026
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Yahoo Finance
Tue, 20 Jan 2026
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
